仅三生物 (Jin San Bio) is a synthetic biology firm focused on R&D, production, and sales of bioactive raw materials for skincare and large-health dietary supplement applications. Its current core products include skincare bioactive ingredients and ingredient applications, and raw materials for health supplements. The company’s key technologies include a large-scale Bacillus screening platform and Bacillus chromosomal editing, and its core raw materials include small-molecule hyaluronic acid, ergothioneine, and probiotics. The founding research team’s core technology traces to Dr. Wang’s group (Oregon State University pharmacy PhD and UIUC postdoctoral researcher), with proprietary R&D capabilities and patents. The company intends to use newly raised funds to accelerate R&D and advance product development. 仅三生物 was founded in August 2021 and is headquartered in Nanjing.

Total raised

$8M

Funding rounds

1

Latest round

Equity

Latest activity

Aug 2023